Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 115 Squamous Cell Carcinoma of Head and Neck 61 Triple Negative Breast Neoplasms 57 Melanoma 54 Neoplasm Metastasis 49 Lung Neoplasms 49 Breast Neoplasms 41 Neoplasms 36 Colorectal Neoplasms 35 Head and Neck Neoplasms 25 Endometrial Neoplasms 25 Carcinoma, Renal Cell 24 Uterine Cervical Neoplasms 21 Stomach Neoplasms 21 Ovarian Neoplasms 21 Carcinoma, Transitional Cell 21 Urinary Bladder Neoplasms 20 Parkinson Disease 4, Autosomal Dominant Lewy Body 18 Esophageal Neoplasms 16 Recurrence 15 Carcinoma, Hepatocellular 14 Pancreatic Neoplasms 13 Sarcoma 12 Carcinoma, Squamous Cell 12 Glioblastoma 11 Esophageal Squamous Cell Carcinoma 11 Carcinoma 11 Prostatic Neoplasms 10 Brain Neoplasms 10 Carcinoma, Merkel Cell 9

Interventions

Radiosurgery 3 Androgen Antagonists 3 pembrolizumab 1 fludrocortisone acetate 1 enzalutamide 1 darolutamide 1 cabazitaxel 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Prednisone 1 Pluvicto 1 Lutetium-177 1 Lutetium 1 Hydrocortisone 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Dexamethasone 1 Carboplatin 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Prostate Cancer Metastatic × pembrolizumab × Clear all

NCT05563558 2024-06-11

PEAPOD_FOS

Fundacion Oncosur

Phase 2 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡